Skip to content

Total Revenue at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$3.61B+19.0%
Bausch + Lomb logo
Bausch + LombBLCO
$1.24B+9.4%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$162.05M+107%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$136M-2.2%
PBH
Prestige Consumer HealthcarePBH
$281.62M-5.0%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$105.4M+60.1%

Segments

By segment

See full
Single Reportable$10.79M+0.8%

Other financials

Income statement

See full
Gross profit$9.5M+0.2%
Operating income-$93.3M-46.0%
Net income-$88.6M-38.3%
EPS (diluted)-$0.40-5.3%

Balance sheet

See full
Cash & equivalents$666.7M+90.7%
Total debt$79.5M+4.2%
Total equity$581.6M+119%
Total assets$732.5M+80.5%

Cash flow

See full
Operating cash flow-$66.0M-47.7%
CapEx$4.7M+141%
Free cash flow-$70.7M-51.6%

Valuation

See full
Market cap$2.21B+58.2%
Enterprise value$1.63B+40.8%
P/S42.6×+19.1×

Profitability

See full
Gross margin87.2%-3.4pp
Operating margin-575.4%+1,233pp
Net margin-558.2%+1,493pp
FCF margin-463%+2,860pp

Returns & leverage

See full
Return on equity-68.6%+17.0pp
Debt / equity0.1×-0.2×
Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ocular Therapeutix's total revenue?
Ocular Therapeutix (OCUL) reported total revenue of $10.79M in Q1 2026.
How has Ocular Therapeutix's total revenue changed year-over-year?
Ocular Therapeutix's total revenue increased by 0.8% year-over-year, from $10.7M to $10.79M.
What is the long-term trend for Ocular Therapeutix's total revenue?
Over 4 years (2021 to 2025), Ocular Therapeutix's total revenue has grown at a 4.5% compound annual growth rate (CAGR), from $43.52M to $51.95M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.